title: Kinases inhibitors and small molecules: A new treatment tool for axial spondyloarthropathy?
authors.affiliation: Service de Rhumatologie, CHRU de Besançon, Boulevard Fleming, 25030 Besançon, France; Université de Franche-Comté, 25030 Besançon, France. Electronic address: dwendling@chu-besancon.fr.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
authors.affiliation: Service de Rhumatologie, CHRU de Besançon, Boulevard Fleming, 25030 Besançon, France; Université de Franche-Comté, 25030 Besançon, France.
authors.forename: Clément
authors.initials: C
authors.lastname: Prati
mesh_terms: D018501:Antirheumatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects; D025241:Spondylarthritis / Q000188:drug therapy; D025242:Spondylarthropathies / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D047428:Protein Kinase Inhibitors; D053612:Janus Kinases
keywords: Apremilast; Janus kinases; Signaling pathways; Spondyloarthritis; Tofacitinib; Treatment